(c) 2024 PillSync.com

mercaptopurine 50 MG Oral Tablet Purinethol

INDICATIONS AND USAGE PURINETHOL (mercaptopurine) is indicated for maintenance therapy of acute lymphatic (lymphocytic, lymphoblastic) leukemia as part of a combination regimen. The response to this agent depends upon the particular subclassification of acute lymphatic leukemia and the age of the patient (pediatric or adult). PURINETHOL is not effective for prophylaxis or treatment of central nervous system leukemia. PURINETHOL is not effective in acute myelogenous leukemia, chronic lymphatic leukemia, the lymphomas (including Hodgkins Disease), or solid tumors.

Gate Pharmaceuticals


3 years ago ROUND YELLOW Purinethol 04A mercaptopurine 50 MG Oral Tablet Purinethol

ROUND YELLOW Purinethol 04A

HOW SUPPLIED Pale yellow to buff, scored tablets containing 50 mg mercaptopurine, imprinted with “PURINETHOL” and “04A”; bottles of 60 (NDC 57844-522-06). Store at 15° to 25°C (59° to 77°F) in a dry place.


More pills like ROUND Purinethol 04A












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site